604311000001102: Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\UK product\Virtual medicinal product\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\UK product\Virtual therapeutic moiety\Co-codamol\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\UK product\Virtual therapeutic moiety\Co-codamol\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\UK product\Trade family\Solpadeine Max\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)

\Medicinal product\Product containing plant material (product)\Product containing phytochemical\Product containing codeine\Product containing codeine and paracetamol\Co-codamol\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Product containing plant material (product)\Product containing phytochemical\Product containing codeine\Product containing codeine and paracetamol\Co-codamol\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Product containing plant material (product)\Product containing phytochemical\Product containing codeine\Product containing codeine and paracetamol\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Product containing plant material (product)\Product containing phytochemical\Product containing codeine\Product containing codeine in oral dose form (medicinal product form)\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Product containing plant material (product)\Product containing plant agent\Product containing codeine\Product containing codeine and paracetamol\Co-codamol\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Product containing plant material (product)\Product containing plant agent\Product containing codeine\Product containing codeine and paracetamol\Co-codamol\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Product containing plant material (product)\Product containing plant agent\Product containing codeine\Product containing codeine and paracetamol\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Product containing plant material (product)\Product containing plant agent\Product containing codeine\Product containing codeine in oral dose form (medicinal product form)\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by disposition\Product containing opioid receptor agonist\Product containing phenanthrene derivative\Product containing codeine\Product containing codeine and paracetamol\Co-codamol\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by disposition\Product containing opioid receptor agonist\Product containing phenanthrene derivative\Product containing codeine\Product containing codeine and paracetamol\Co-codamol\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by disposition\Product containing opioid receptor agonist\Product containing phenanthrene derivative\Product containing codeine\Product containing codeine and paracetamol\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by disposition\Product containing opioid receptor agonist\Product containing phenanthrene derivative\Product containing codeine\Product containing codeine in oral dose form (medicinal product form)\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing paracetamol\Product containing paracetamol in oral dose form (medicinal product form)\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing paracetamol\Product containing codeine and paracetamol\Co-codamol\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing paracetamol\Product containing codeine and paracetamol\Co-codamol\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing paracetamol\Product containing codeine and paracetamol\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing naturally occurring alkaloid\Product containing codeine\Product containing codeine and paracetamol\Co-codamol\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing naturally occurring alkaloid\Product containing codeine\Product containing codeine and paracetamol\Co-codamol\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing naturally occurring alkaloid\Product containing codeine\Product containing codeine and paracetamol\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing naturally occurring alkaloid\Product containing codeine\Product containing codeine in oral dose form (medicinal product form)\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing paracetamol\Product containing paracetamol in oral dose form (medicinal product form)\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing paracetamol\Product containing codeine and paracetamol\Co-codamol\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing paracetamol\Product containing codeine and paracetamol\Co-codamol\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing paracetamol\Product containing codeine and paracetamol\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing phenanthrene derivative\Product containing codeine\Product containing codeine and paracetamol\Co-codamol\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing phenanthrene derivative\Product containing codeine\Product containing codeine and paracetamol\Co-codamol\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing phenanthrene derivative\Product containing codeine\Product containing codeine and paracetamol\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by structure\Product containing phenanthrene derivative\Product containing codeine\Product containing codeine in oral dose form (medicinal product form)\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antitussive agent (product)\Product containing codeine in oral dose form (medicinal product form)\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Product manufactured as oral dose form\Product containing paracetamol in oral dose form (medicinal product form)\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)
\Medicinal product\Product manufactured as oral dose form\Product containing codeine in oral dose form (medicinal product form)\Product containing codeine and paracetamol in oral dose form (medicinal product form)\Product containing only codeine and paracetamol in oral dose form (medicinal product form)\Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet\Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

17105901000001118 Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

72642801000001118 Solpadeine Max 12.8mg/500mg tablets (Omega Pharma Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category Schedule 5 (CD Inv)	true	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Is a	Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Has excipient	Excipient not declared	false	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Has active ingredient	Codeine phosphate	false	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Has active ingredient	Paracetamol	false	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Is a	Solpadeine Max	true	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Has specific active ingredient	Paracetamol	true	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Has specific active ingredient	Codeine phosphate	true	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare) 20 tablet	Is pack of	False	Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare) 30 tablet	Is pack of	False	Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare) 30 tablet	Has AMP	True	Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Inferred relationship	Existential restriction modifier
Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare) 20 tablet	Has AMP	True	Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
17105901000001118	Solpadeine Max 12.8mg/500mg tablets (GlaxoSmithKline Consumer Healthcare) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
72642801000001118	Solpadeine Max 12.8mg/500mg tablets (Omega Pharma Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module